STERIS director granted options and RSUs

STERIS plc director Esther M. Alegria received new equity-based compensation.

Rhea-AI Filing Summary

STERIS plc director Esther M. Alegria received new equity-based compensation. On 2026-08-10 she was granted 1,506 nonqualified stock options with an exercise price of $238.91 per share, expiring on 2036-08-10; these options are fully vested and exercisable immediately. She was also granted 512 Career Restricted Stock Units, each representing one ordinary share, which are fully vested and will be settled in shares six months after her Board service ends. Following these awards, her directly held derivative interests reported in this filing total 3,408 Career RSUs and 1,506 stock options.

Insider Trade Summary

Grant/Award: 2,018 shares

Grant/Award 2 txns

Insider Alegria Esther M.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Director Stock Option (right to buy) F1	1,506	$0.00	$0.00
Grant/Award	Career Restricted Stock Units F2, F3	512	$0.00	$0.00

Holdings After Transaction: Director Stock Option (right to buy) — 1,506 contracts (Direct); Career Restricted Stock Units — 3,408 contracts (Direct)

Footnotes (3)

1. F1. These nonqualified stock options are fully vested and are exercisable immediately.
2. F2. Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service.
3. F3. These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service.

Key Figures

Stock options granted: 1,506 shares Option exercise price: $238.91 per share Option expiration date: 2036-08-10 +3 more

6 metrics

Stock options granted 1,506 shares Nonqualified stock options granted to Esther M. Alegria on 2026-08-10

Option exercise price $238.91 per share Exercise price for 1,506 nonqualified stock options

Option expiration date 2036-08-10 Expiration of nonqualified stock options granted 2026-08-10

Career RSUs granted 512 units Career Restricted Stock Units granted to Esther M. Alegria on 2026-08-10

Total Career RSUs after grant 3,408 units Director’s directly owned Career RSUs following the 512-unit grant

Total stock options after grant 1,506 options Director’s directly owned options following the grant

Key Terms

Nonqualified stock options, Career Restricted Stock Units, fully vested

3 terms

Nonqualified stock options financial

"These nonqualified stock options are fully vested and are exercisable immediately."

A nonqualified stock option is a company-issued right that lets an employee or contractor buy shares later at a preset price, like a coupon to purchase stock regardless of the market price. It matters to investors because when the option is used the recipient owes ordinary-income tax on the difference between market and preset price, which affects the holder’s financial decisions and can change the company’s share count and reported expenses.

Career Restricted Stock Units financial

"Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share"

fully vested financial

"These Career Restricted Stock Units are fully vested immediately."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did STERIS (STE) director Esther M. Alegria receive?

Director Esther M. Alegria received 1,506 nonqualified stock options with a $238.91 exercise price and 512 Career Restricted Stock Units on 2026-08-10 as part of her equity-based compensation.

When do Esther M. Alegria’s new STERIS (STE) stock options vest and expire?

The 1,506 nonqualified stock options granted to Esther M. Alegria are fully vested and exercisable immediately and have an expiration date of 2036-08-10, providing a ten-year exercise window.

What are STERIS (STE) Career Restricted Stock Units granted to Esther M. Alegria?

Each of the 512 Career Restricted Stock Units represents the right to receive one STERIS ordinary share, fully vested immediately and payable in shares six months after the cessation of her Board service.

How many STERIS (STE) derivative awards does Esther M. Alegria hold after these grants?

After the 2026-08-10 grants, Esther M. Alegria holds 1,506 stock options and 3,408 Career Restricted Stock Units in total, all reported as direct beneficial ownership in this Form 4 filing.

Did Esther M. Alegria buy or sell STERIS (STE) shares in the market?

No market purchases or sales were reported. The Form 4 only shows acquisitions via equity grants (stock options and Career RSUs) with no buy or sell transactions disclosed.

Are Esther M. Alegria’s new STERIS (STE) equity awards under a Rule 10b5-1 plan?

The filing’s Rule 10b5-1 checkbox is not marked as an affirmative plan, and the footnotes do not indicate a trading plan, suggesting these are standard director compensation grants.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/12/2026 - 04:31 PM Accepted by SEC EDGAR 08/12/2026 - 04:31 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Alegria Esther M.

(Last) (First) (Middle)

C/O 70 SIR JOHN ROGERSON'S QUAY

(Street)

DUBLIN 2 D02 R296

(City) (State) (Zip)

IRELAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
STERIS plc [ STE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Director Stock Option (right to buy)	$238.91	08/10/2026		A		1,506		(1)	08/10/2036	Ordinary Shares	1,506	$0	1,506	D
Career Restricted Stock Units	(2)	08/10/2026		A		512		(3)	(3)	Ordinary Shares	512	$0	3,408	D

Explanation of Responses:

1. These nonqualified stock options are fully vested and are exercisable immediately.

2. Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service.

3. These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service.

Remarks:

	/s/ John P. Ubbing, Authorized Representative under Power of Attorney	08/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)